CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2019)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

CollPlant Biotechnologies' Current Deferred Revenue history spans 2 years, with the latest figure at $942000.0 for Q4 2019.

• For Q4 2019, Current Deferred Revenue fell 2.89% year-over-year to $942000.0; the TTM value through Dec 2019 reached $942000.0, down 2.89%, while the annual FY2019 figure was $942000.0, 2.89% down from the prior year.
• Current Deferred Revenue reached $942000.0 in Q4 2019 per CLGN's latest filing, down from $970000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $970000.0 in Q4 2018 to a low of $942000.0 in Q4 2019.

Peer Comparison